JMDC Inc. (TYO:4483)
Japan · Delayed Price · Currency is JPY 3,740.00
-110.00 (-2.86%)
Nov 13, 2026, 3:30 PM JST
JMDC Inc. Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 54,953 | 50,462 | 41,722 | 32,381 | 27,809 | 21,814 |
Revenue Growth | 20.50% | 20.95% | 28.85% | 16.44% | 27.48% | 30.07% |
Gross Profit Gross Profit Growth | 29,991 | 27,688 | 23,849 | 19,253 | 15,859 | 12,589 |
Operating Income Operating Income Growth | 11,103 | 10,523 | 8,761 | 6,522 | 5,869 | 4,868 |
Net Income Net Income Growth | 7,340 | 6,765 | 7,275 | 4,607 | 4,267 | 3,258 |
Earnings Per Share EPS Growth | 111.18 | 102.46 | 110.22 | 69.95 | 67.69 | 54.35 |
EPS Growth | -1.64% | -7.04% | 57.57% | 3.34% | 24.55% | 25.00% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Tele-Medicine Tele-Medicine Growth | 6,392 | 6,117 | 5,579 | 5,038 | 4,441 |
Healthcare-Big Data Healthcare-Big Data Growth | 44,070 | 35,646 | 25,058 | 19,221 | 14,019 |
Unallocated Adjustment Unallocated Adjustment Growth | - | -41 | -115 | -277 | -228 |
Total Total Growth | 50,462 | 41,722 | 32,381 | 27,808 | 21,814 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 29,104 | 28,950 | 32,176 | 14,473 | 22,782 | 13,192 |
Total Debt Total Debt Growth | 50,625 | 52,046 | 46,888 | 37,831 | 20,398 | 17,795 |
Net Cash (Debt) Net Cash Growth | -21,521 | -23,096 | -14,712 | -23,358 | 2,384 | -4,603 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -325.96 | -349.79 | -222.89 | -354.62 | 37.81 | -76.76 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 10,035 | 8,594 | 14,685 | -17 | 4,062 | 3,808 |
Capital Expenditures CapEx Growth | -790 | -581 | -2,119 | -893 | -822 | -446 |
Free Cash Flow Free Cash Flow Growth | 9,245 | 8,013 | 12,566 | -910 | 3,240 | 3,362 |
Free Cash Flow Growth | -3.47% | -36.23% | - | - | -3.63% | 87.61% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.58% | 54.87% | 57.16% | 59.46% | 57.03% | 57.71% |
Operating Margin | 20.21% | 20.85% | 21.00% | 20.14% | 21.11% | 22.32% |
Pretax Margin | 19.37% | 19.75% | 20.40% | 21.33% | 21.12% | 21.94% |
Profit Margin | 13.36% | 13.41% | 17.44% | 14.23% | 15.34% | 14.94% |
FCF Margin | 16.82% | 15.88% | 30.12% | -2.81% | 11.65% | 15.41% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 18.000 | 18.000 | 16.000 | 14.000 | 12.000 | 10.000 |
Dividend Per Share Growth | 12.50% | 12.50% | 14.29% | 16.67% | 20.00% | - |
Dividend Yield | 0.48% | 0.56% | 0.58% | 0.39% | 0.26% | 0.15% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.64 | 31.34 | 24.80 | 51.18 | 67.06 | 117.23 |
Forward PE | 27.95 | 25.21 | 23.83 | 32.98 | 56.92 | 84.11 |
P/FCF Ratio | 26.48 | 26.46 | 14.36 | - | 88.31 | 113.60 |
PS Ratio | 4.45 | 4.20 | 4.32 | 7.28 | 10.29 | 17.51 |